- March 12, 2021
John M. Carethers, M.D., MACP: C. Richard Boland Distinguished University Professor; John G. Searle Professor and Chair, Department of Internal Medicine; Professor, Human Genetics, University of Michigan
Nicole J. Gormley, M.D.: Division Director, Division of Hematologic Malignancies 2, Office of Oncologic Disease, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Yang-Min (Max) Ning, M.D., Ph.D.: ABIM Board-certified Medical Oncologist and Clinical Reviewer, Division of Clinical Compliance Evaluation, Office of Scientific Investigations, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Phyllis Rodgers: Cancer Survivor & Founder and CEO of Peer Plus Education and Training Advocates
Christine Ann Tran, MS, RN, OCN, AGCNS-BC: Clinical Nurse Specialist, Memorial Sloan-Kettering Cancer Center, Evidence-based Practice
Hung Wang, BA, BSN, PHN, RN: LVN Adjunct, Pasadena City College, Clinical Nurse III, City of Hope
Over the past year, COVID-19 has changed life as we know it. No one knows this better than people with cancer, their caregivers, the providers who care for them, and those moving the oncology field forward. Join a lively Oncology Center of Excellence panel discussion about how COVID-19 has impacted every aspect of cancer care, from the personal to professional, and what cancer care may look like going forward.
FDA provided a free-of-charge, live webcast of this workshop.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov.